| Members | targetComponentId | 
| Diff. white cell count NOS | Differential white blood cell count procedure (procedure) | 
| Diff. white cell count NOS | Differential white blood cell count procedure (procedure) | 
| vanskelig intubation | Difficult intubation | 
| besvær med at tale | Difficulty talking | 
| nodalt/systemisk diffust storcellet B-celle-lymfom med hudinvolvering | Diffuse large B-cell malignant lymphoma (disorder) | 
| diffust storcellet B-celle-lymfom iht. kategori | Diffuse large B cell malignant lymphoma (morphologic abnormality) | 
| diffus Brocqs neurodermatit | Atopic dermatitis (disorder) | 
| Diffuse non-Hodgkin's lymphoblastic (diffuse) lymphoma | Precursor cell lymphoblastic lymphoma | 
| lymfoblastært non-Hodgkin-lymfom af diffus type | Precursor cell lymphoblastic lymphoma | 
| diffus unilateral subakut neuroretinit | Diffuse unilateral subacute neuroretinitis | 
| diflucan oral suspension | Fluconazole-containing product in oral dose form | 
| Difluprednate 0.05% ophthalmic emulsion | Difluprednate 500 microgram/mL eye suspension | 
| fordøjelsesmiddel | Digestant (substance) | 
| endoskop til fordøjelseskanalen | Endoscope | 
| Digestive function tests NOS | Digestive function tests | 
| Digestive function tests NOS | Digestive function tests | 
| Digestive system diseases NOS | Disorder of digestive system (disorder) | 
| Digestive system diseases NOS | Disorder of digestive system (disorder) | 
| Digoxin 38mg/vial injection | Digoxin immune fab only product | 
| digoxin-antistof Fab-fragment 38 mg/hætteglas, pulver til injektionsvæske, 4 ml hætteglas | Digoxin immune fab only product | 
| digoxinspecifikt antistof 38 mg pulver til injektionsvæske, opløsning, hætteglas | Digoxin immune fab only product | 
| antipsykotisk dihydrocarbostyrilderivatmiddel | Dihydrocarbostyril derivative | 
| dihydroergotaminmesylat 1 mg/ml injektionsvæske, opløsning, ampul | Product containing precisely dihydroergotamine mesilate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) | 
| dihydroergotaminmesylat 4 mg/1 ml næsespray | Product containing precisely dihydroergotamine mesilate 500 microgram/1 actuation conventional release nasal spray (clinical drug) | 
| allergi over for dihydroergotaminmesylat | Allergy to dihydroergotamine | 
| Dihydrofolate reductase deficiency | Deficiency of dihydrofolate reductase | 
| antipsykotisk dihydroindolonderivatmiddel | Dihydroindolone derivative (substance) | 
| dihydrotachysterol 0,2 mg/ml | Product containing dihydrotachysterol (medicinal product) | 
| dihydrotachysterol 170 mg | Product containing dihydrotachysterol (medicinal product) | 
| Dilatation og curettage, ikke nærmere specificeret | Dilation and curettage | 
| Dilatation and curettage NOS | Dilation and curettage | 
| Dilatation of gastrointestinal tract NOS | Dilation of gastrointestinal tract | 
| Dilatation of gastrointestinal tract NOS | Dilation of gastrointestinal tract | 
| Dilatation: [other opening] or [non GIT] | Dilation procedure | 
| Dilatation: [other opening] or [non GIT] | Dilation procedure | 
| Dilatation af cervix uteri og curettage af uterus, ikke klassificeret andetsteds | Dilation and curettage of uterus | 
| Dilation of cervix uteri and curettage of uterus NEC | Dilation and curettage of uterus | 
| Dilatation af cervix uteri og evakuering af graviditetsprodukt fra uterus, ikke klassificeret andetsteds | Evacuation of retained product of conception | 
| Dilation of colon | Dilation of colon | 
| Dilation of colostomy stoma | Dilation of colostomy stoma | 
| Dilation of mature percutaneous transhepatic biliary drainage tract under radiological guidance | Fluoroscopy guided dilation of mature percutaneous transhepatic biliary drainage tract | 
| Dilation of organ NOC | Dilation procedure | 
| Dilation of organ NOC NOS | Dilation procedure | 
| Dilation of stricture of organ NOC | Dilation procedure | 
| diltiazem 180 mg tablet med modificeret udløsning | Diltiazem only product in oral dose form | 
| Diltiazem 180mg prolonged-release oral tablet | Diltiazem only product in oral dose form | 
| diltiazem 240 mg tablet med modificeret udløsning | Diltiazem only product in oral dose form | 
| Diltiazem 240mg prolonged-release oral tablet | Diltiazem only product in oral dose form | 
| diltiazem 300 mg tablet med modificeret udløsning | Diltiazem only product in oral dose form | 
| Diltiazem 300mg prolonged-release oral tablet | Diltiazem only product in oral dose form | 
| Diltiazem 360mg m/r tablet | Diltiazem only product in oral dose form | 
| Diltiazem 360mg prolonged-release oral tablet | Diltiazem only product in oral dose form | 
| diltiazem 420 mg tablet med modificeret udløsning | Diltiazem only product in oral dose form | 
| Diltiazem 420mg prolonged-release oral tablet | Diltiazem only product in oral dose form | 
| diltiazemhydrochlorid 420 mg kapsel med modificeret udløsning | Diltiazem only product in oral dose form | 
| Diltiazem hydrochloride 420mg prolonged-release oral capsule | Diltiazem only product in oral dose form | 
| diltiazemhydrochlorid 5 mg/ml opløsning | Product containing only diltiazem in parenteral dose form (medicinal product form) | 
| Dimeglumine gadopentetate | Product containing gadopentetic acid (medicinal product) | 
| Dimeglumine gadopentetate | Product containing gadopentetic acid (medicinal product) | 
| dimeglumingadopentetat 469,01 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte | Gadopentetic acid only product | 
| dimeglumingadopentetat 469,01 mg/ml injektionsvæske, opløsning, hætteglas | Gadopentetic acid only product | 
| Dingo dog breed | Canis lupus dingo | 
| Dinoprostone 10mg insert | Dinoprostone 10 mg prolonged-release vaginal pessary | 
| dinoproston 10 mg vagitorium | Dinoprostone 10 mg prolonged-release vaginal pessary | 
| dinoproston 10 mg/ml koncentrat til infusionsvæske, ampul a 0,5 ml | Dinoprostone 10 mg/mL solution for injection | 
| dinoproston 1 mg/ml koncentrat til infusionsvæske, ampul a 0,75 ml | Dinoprostone 1 mg/mL solution for injection | 
| Dioxygenase | Dioxygenase (substance) | 
| Dipeptide hydrolase | Dipeptide hydrolase | 
| Dipeptidylcarboxypeptidase II | Dipeptidyl carboxypeptidase II (substance) | 
| Dipeptidylpeptide hydrolase | Dipeptidylpeptide hydrolase | 
| Dipetalonema perstans | Mansonella perstans | 
| diphenhydramin 2 % + zinkacetat 0,1 % creme til topikal anvendelse | Diphenhydramine hydrochloride 20 mg/mL and zinc acetate 1 mg/mL cutaneous cream | 
| diphenhydraminhydrochlorid eliksir 12,5 mg/5 ml | Product containing precisely diphenhydramine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) | 
| diphenhydraminhydrochlorid 12,5 mg/5 ml syrup | Product containing precisely diphenhydramine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) | 
| Diphenhydramine hydrochloride 6.25mg/5mL syrup | Diphenhydramine hydrochloride 1.25 mg/mL oral solution | 
| diphenhydraminhydrochlorid 6,25 mg/5 ml syrup | Diphenhydramine hydrochloride 1.25 mg/mL oral solution | 
| difenylmethandiisocyanat-specifikt ekstrakt | Diphenylmethane di-isocyanate | 
| Diphtheria and tetanus double vaccination NOS | Administration of diphtheria and tetanus vaccine | 
| dobbeltvaccination mod difteri og stivkrampe, ikke nærmere specificeret | Administration of diphtheria and tetanus vaccine | 
| difteritoxin til kutantest | Diphtheria toxin | 
| Diphtheria vaccination NOS | Administration of diphtheria vaccine | 
| difterivaccination, ikke nærmere specificeret | Administration of diphtheria vaccine | 
| Diphtheria, pertussis and tetanus triple vaccination | Administration of diphtheria, pertussis, and tetanus vaccine | 
| Diphtheria, pertussis and tetanus triple vaccination NOS | Administration of diphtheria, pertussis, and tetanus vaccine | 
| vaccination mod difteri, kighoste og stivkrampe, ikke nærmere specificeret | Administration of diphtheria, pertussis, and tetanus vaccine | 
| dipivefrinhydrochlorid 0,1 % øjendråber | Dipivefrine hydrochloride 1 mg/mL eye solution | 
| Dipivefrin hydrochloride 0.1% ophthalmic solution | Dipivefrine hydrochloride 1 mg/mL eye solution | 
| Dipivefrin hydrochloride 0.1%wv solution | Dipivefrine hydrochloride 1 mg/mL eye solution | 
| Direct inguinal hernia NOS | Direct inguinal hernia (disorder) | 
| direkte ingvinalhernie, ikke nærmere specificeret | Direct inguinal hernia (disorder) | 
| Direkte indvækst i binyre (T3a) | American Joint Committee on Cancer cT3a (qualifier value) | 
| Direkte laryngoskopi med injektion i stemmelæbe, terapeutisk | Direct laryngoscopy with injection into vocal cord (procedure) | 
| Direkte laryngoskopi, diagnostisk, nyfødt | Direct laryngoscopy | 
| Direkte diagnostisk laryngoskopi med operationsmikroskop | Direct laryngoscopy with operating microscope (procedure) | 
| kolangiografi ved direkte peroperativ punktur | Intraoperative fluoroscopic cholangiography by direct puncture with contrast (procedure) | 
| Director/producer/manager NOS | Directors/producers/managers | 
| Director/producer/manager NOS | Directors/producers/managers | 
| Dirty environment | Dirty environment (finding) | 
| Disabled driver report NOS | Disabled driver report status (finding) | 
| Disabled driver report NOS | Disabled driver report status (finding) | 
| Disabled registration application - NOS | Disabled registration application status |